Istaroxime-containing intravenous formulation for the treatment of acute heart failure (AHF) | Patent Number 11583540

US 11583540 B2
Application Number17517530
Publication NumberUS 20220054502 A1
Pendency1 year, 3 months, 21 days
Filled DateNov 2, 2021
Priority DateMar 5, 2019
Publication DateFeb 24, 2022
Expiration DateMar 4, 2039
Inventor/ApplicantsPaolo Barassi
Giuseppe Bianchi
Mara Ferrandi
Patrizia Ferrari
ExaminesROZOF, TIMOTHY R
Art Unit1625
Technology Center1600
Assignments
Windtree Therapeutics Inc.
Current
Windtree Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.